Wednesday, July 8, 2026

Patent intelligence · US

US 8129510

Minigene expression cassette

granted A61KA61K48/0058A61K48/0066
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 6
Applicant portfolio 13
Patent details — US 8129510
Jurisdiction
US
Status
granted
Grant date
Mar 6, 2012
Expiration
Mar 1, 2032
Claims
9
CPC classes
A61K, A61K48/0058, A61K48/0066
View on Google Patents ↗

Quick answer

US 8129510 (Minigene expression cassette) is held by Benitec Biopharma Limited. Status: granted. Granted Mar 6, 2012. Expires Mar 1, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
9
CPC classes
A61K, A61K48/0058, A61K48/0066

More from Benitec Biopharma Limited

Related pharmaceutical patents in our USPTO index.

  1. US 11932852

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec IP Holdings Inc. · Expires Mar 14, 2044

    granted
  2. US 11535851

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Benitec IP Holdings Inc. · Expires Dec 22, 2042

    granted
  3. US 11234994

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec Biopharma Limited · Expires Jan 27, 2042

    granted
  4. US 11142765

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec IP Holdings Inc. · Expires Oct 7, 2041

    granted
  5. US 10898505

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Benitec Biopharma Limited · Expires Jan 21, 2041

    granted
  6. US 10000753

    Age-related macular degeneration treatment

    Benitec Biopharma Limited · Expires Jun 14, 2038

    granted
  7. US 9518260

    Pain treatment

    Benitec Biopharma Limited · Expires Dec 8, 2036

    granted
  8. US 9410154

    HBV treatment

    Benitec Biopharma Limited · Expires Aug 4, 2036

    granted

Frequently asked questions

What is US patent 8129510?

US 8129510 (Minigene expression cassette) is held by Benitec Biopharma Limited. Status: granted. Granted Mar 6, 2012. Expires Mar 1, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 8129510?

Benitec Biopharma Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 13 pharmaceutical patents for this assignee.

When does US 8129510 expire?

Our index shows an expiration date of Mar 1, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.